MCK
MCK
NYSE · Health Care

Mckesson Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks
$869.58
-1.80 (-0.21%)
As of Aug 9, 9:31 PM ET ·
MCK News2 articles
Medline's $2.7B Secondary Offering Tests Post-IPO Demand
Medline Inc. shareholders sold 72.55 million Class A shares at $37 each in an upsized secondary offering, with the stock closing at $37.01 on Friday. The deal closes May 28.
IPO
Medline's $2.7B Secondary Offering Tests Post-IPO Demand
Medline's $2.68 billion secondary offering, upsized from 60 million shares, prices at $37 each, with the stock holding near that level.
IPO